202 results on '"Zillioux, Jacqueline"'
Search Results
2. Patient and Clinician Challenges with Anticholinergic Step Therapy in the Treatment of Overactive Bladder: A Narrative Review
3. Sacral neuromodulation update in 2024: Insights from the ICS workshop 2023
4. Longitudinal urgency outcomes following robotic-assisted laparoscopic prostatectomy
5. Anticholinergic Use for OAB in the Older Woman: An Update
6. Patient perceived improvement and medication resumption rates after intradetrusor onabotulinumtoxina for idiopathic urgency urinary incontinence
7. Sacral neuromodulation device biofilm differs in the absence and presence of infection, harbors antibiotic resistance genes, and is reproducible in vitro
8. Prevalence of Cognitive and Manual Dexterity Disorders Among Men Following Artificial Urinary Sphincter Placement
9. MP03-06 INCIDENCE OF COGNITIVE AND MANUAL DEXTERITY DISORDERS AMONG MEN WITH ARTIFICIAL URINARY SPHINCTERS: A SEER MEDICARE STUDY
10. PD59-12 DOES COGNITIVE IMPAIRMENT IMPACT SACRAL NEUROMODULATION SUCCESS IN OLDER ADULTS?
11. PD43-07 SACRAL NEUROMODULATION DEVICE BIOFILMS DIFFER IN COMPOSITION BY INFECTION STATUS AND TESTING PHASE
12. PD59-07 SACRAL NEUROMODULATION DEVICE BIOFILMS HARBOR RIFAMPIN AND MINOCYCLINE RESISTANCE GENES AND ARE RECONSTITUTABLE ON TITANIUM, CERAMIC, AND OTHER MEDICAL MATERIALS
13. MP23-07 PILOT STUDY OF NOVEL ONLINE COMPREHENSIVE PELVIC FLOOR PROGRAM IN THE TREATMENT OF URINARY INCONTINENCE IN WOMEN
14. Pelvic Floor Muscle Training in the Management of Female Pelvic Floor Disorders
15. Pelvic floor therapy program for the treatment of female urinary incontinence in Belize: a pilot study
16. Economic Impact of Urological Conditions in Men and Women in Belize
17. Neuromodulation for lower urinary tract dysfunction: indications
18. Opioid prescription use in patients with interstitial cystitis
19. Economic impact of urinary incontinence and pelvic organ prolapse in women in Belize
20. The impact of cognitive impairment in urologic implants: a narrative review
21. Predictors of pelvic pain in a general urology clinic population
22. Predictors of urinary outcomes following robotic‐assisted laparoscopic prostatectomy
23. Tele-Urology During COVID-19: Rapid Implementation of Remote Video Visits
24. PD33-08 BACTERIAL BIOFILMS FROM INDWELLING SACRAL NEUROMODULATION DEVICES ARE RECONSTITUTABLE IN VITRO AND EXHIBIT DIFFERENTIAL FORMATION BY MATERIAL TYPE
25. MP37-07 COGNITIVE IMPAIRMENT, TECHNOPHILIA, AND SACRAL NEUROMODULATION DEVICE USE IN AN OLDER PATIENT POPULATION WITH OVERACTIVE BLADDER
26. MP74-12 THE URINARY MICROBIOME IN THOSE WITH OVERACTIVE BLADDER IS MORE ABUNDANT IN ESCHERICHIA AND LESS ABUNDANT IN LACTOBACILLUS RELATIVE TO THAT OF HEALTHY CONTROLS
27. MP07-12 PELVIC FLOOR SUPPORT FOLLOWING FEMALE RADICAL CYSTECTOMY: A LONGITUDINAL OBSERVATIONAL STUDY
28. MP49-04 PILOT PELVIC FLOOR THERAPY PROGRAM FOR THE TREATMENT OF FEMALE URINARY INCONTINENCE IN BELIZE
29. PD19-08 THE URINARY FUNGAL MICROBIOME IN THOSE WITH OVERACTIVE BLADDER IS LESS ABUNDANT IN MALASSEZIA AND MORE ABUNDANT IN ASPERGILLUS RELATIVE TO HEALTHY CONTROLS
30. V12-08 TRANSVESICAL SINGLE PORT ROBOTIC VESICOVAGINAL FISTULA REPAIR
31. Assessment of urinary tract dilation grading amongst pediatric urologists
32. Identifying and addressing training deficiencies in the examination of cryptorchidism—a quality improvement study
33. Cognitive impairment does not impact sacral neuromodulation implant rates for overactive bladder
34. Management of Penile Calciphylaxis: A Case Study
35. Overactive Bladder and Cognitive Impairment: The American Urogynecologic Society and Pelvic Floor Disorders Research Foundation State-of-the-Science Conference Summary Report
36. Evidence-Informed, Interdisciplinary, Multidimensional Action Plan to Advance Overactive Bladder Research and Treatment Initiatives: Directives From State-of-the-Science Conference on Overactive Bladder and Cognitive Impairment
37. SUFU white paper on overactive bladder anticholinergic medications and dementia risk
38. Impact of Duration of Antibiotic Prophylaxis on Incidence of UTI after OnabotulinumtoxinA Injection
39. Patient perceived improvement and medication resumption rates after intradetrusor onabotulinumtoxina for idiopathic urgency urinary incontinence
40. Third‐line therapy for overactive bladder in the elderly: Nuances and considerations
41. V06-10 ROBOTIC UTEROSACRAL LIGAMENT PLICATION AT TIME OF BENIGN CYSTECTOMY
42. PD34-05 DOES COGNITIVE IMPAIRMENT IMPACT SACRAL NEUROMODULATION IN OLDER PATIENTS WITH OVERACTIVE BLADDER?
43. PD34-04 IMPACT OF COGNITIVE FUNCTION IN OLDER PATIENTS UNDERGOING SACRAL NEUROMODULATION FOR OVERACTIVE BLADDER: A PROSPECTIVE STUDY
44. PD21-12 MICROBIOTA AND METABOLITES ARE CONSISTENTLY PRESENT ON IMPLANTED UROLOGICAL DEVICES AND DIFFER SIGNIFICANTLY BASED ON INFECTION STATUS AND DEVICE TYPE
45. V06-05 OFFICE REMOVAL OF SACRAL NEUROMODULATION- WELL TOLERATED, SAFE AND EFFECTIVE
46. PD34-01 SACRAL NEUROMODULATION DEVICES CONSISTENTLY HARBOR BACTERIA AND POSSESS A UNIQUE MICROBE AND METABOLITE PROFILE
47. Predictors of prolonged admission after outpatient female pelvic reconstructive surgery
48. Editorial Commentary
49. Is sacral neuromodulation effective in patients with Parkinson's disease? A retrospective review
50. Evidence-Informed, Interdisciplinary, Multidimensional Action Plan to Advance Overactive Bladder Research and Treatment Initiatives: Directives From State-of-the-Science Conference on Overactive Bladder and Cognitive Impairment.
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.